Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss. [electronic resource]
- Life sciences Nov 2009
- 685-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1879-0631
10.1016/j.lfs.2009.09.009 doi
3T3 Cells Alkaline Phosphatase--metabolism Animals Apoptosis--genetics Biomechanical Phenomena Blotting, Western Bone Density--drug effects Bone Matrix--drug effects Bone Remodeling--drug effects Bone and Bones--anatomy & histology Calcification, Physiologic--drug effects Cell Differentiation--drug effects Enzyme Inhibitors--pharmacology Glucocorticoids--antagonists & inhibitors Glycogen Synthase Kinase 3--antagonists & inhibitors Immunohistochemistry Indoles--pharmacology Methylprednisolone--antagonists & inhibitors Mice Osteoblasts--drug effects Oximes--pharmacology Rats Reverse Transcriptase Polymerase Chain Reaction Transfection beta Catenin--metabolism